What is the recommended dosing for trazodone (antidepressant) for patients with insomnia or depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone Dosing for Insomnia and Depression

For depression, trazodone should be started at 150 mg/day in divided doses and may be increased to a maximum of 400 mg/day for outpatients or 600 mg/day for inpatients; for insomnia, a lower dose of 25-50 mg at bedtime is typically effective. 1

Dosing for Depression

Trazodone is FDA-approved for the treatment of major depressive disorder with the following dosing recommendations:

  • Initial dose: 150 mg/day in divided doses 1
  • Dose titration: Increase by 50 mg/day every 3-4 days based on response and tolerability 1
  • Maximum dose:
    • Outpatients: 400 mg/day in divided doses 1
    • Inpatients: 600 mg/day in divided doses 1

Administration considerations:

  • Take shortly after a meal or light snack 1
  • Can be swallowed whole or broken along score line 1
  • A major portion of the daily dose may be administered at bedtime to manage drowsiness 1

Dosing for Insomnia (Off-Label Use)

Although not FDA-approved for insomnia, trazodone is widely prescribed for this indication:

  • Initial dose: 25 mg at bedtime 2
  • Effective dose range: 25-100 mg at bedtime 3
  • Maximum dose for insomnia: 200-400 mg per day in divided doses 2

Research shows that lower doses (25-75 mg) are often more effective for insomnia than higher doses, with the highest percentage of responders at the minimum dose of 25 mg 4.

Clinical Considerations

For Depression

  • Trazodone requires 4-8 weeks for a full therapeutic trial 2
  • Dose increases should use increments of initial dose every 5-7 days 2
  • After 9 months, consider dose reduction to reassess need for medication 2
  • Discontinuation should occur gradually over 10-14 days to limit withdrawal symptoms 2

For Insomnia

  • Low-dose trazodone (≤100 mg/day) has demonstrated efficacy for both primary insomnia and secondary insomnia related to depression and other conditions 3
  • Side effects are dose-dependent, with drowsiness being most common 3
  • For patients with primarily sleep onset issues, alternative agents like ramelteon or low-dose Z-drugs may be more appropriate 5

Special Populations

  • Elderly patients: Start at lower doses due to increased risk of side effects
  • Patients with cardiovascular disease: Use with caution due to risk of orthostatic hypotension 2

Side Effects and Monitoring

Common side effects include:

  • Somnolence (most common)
  • Headache
  • Dizziness
  • Xerostomia (dry mouth) 6

Serious but less common side effects:

  • Orthostatic hypotension (especially in elderly or those with cardiovascular disease)
  • QT interval prolongation
  • Cardiac arrhythmias
  • Rare episodes of priapism 6

Drug Interactions

  • Strong CYP3A4 inhibitors: Consider reducing trazodone dose based on tolerability 1
  • Strong CYP3A4 inducers: Consider increasing trazodone dose based on therapeutic response 1
  • MAOIs: Allow at least 14 days between discontinuing an MAOI and starting trazodone, and vice versa 1

Trazodone's efficacy for depression is comparable to other antidepressants, with the added benefit of improving insomnia symptoms without the sexual dysfunction or weight gain often associated with SSRIs 6, 7.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.